Literature DB >> 19766539

Cortical kindling induces elevated levels of AMPA and GABA receptor subunit mRNA within the amygdala/piriform region and is associated with behavioral changes in the rat.

Amy K Henderson1, Michael A Galic, G Campbell Teskey.   

Abstract

Cortical kindling causes alterations within the motor cortex and results in long-standing motor deficits. Less attention has been directed to other regions that also participate in the epileptiform activity. We examined if cortical kindling could induce changes in excitatory and inhibitory receptor subunit mRNA in the amygdala/piriform regions and if such changes are associated with behavioral deficits. After cortical kindling, amygdala/piriform regions were dissected to analyze mRNA levels of NMDA, AMPA, and GABA receptor subunits using reverse transcription polymerase chain reaction, or rats were subjected to a series of behavioral tests. Kindled rats had significantly greater amounts of GluR1 and GluR2 AMPA receptor mRNA, and alpha1 and alpha2 GABA receptor subunit mRNA, compared with sham controls, which was associated with greater anxiety-like behaviors in the elevated plus maze and reduced freezing behaviors in the fear conditioning task. In summary, cortical kindling produces dynamic receptor subunit changes in regions in addition to the seizure focus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19766539     DOI: 10.1016/j.yebeh.2009.08.015

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  2 in total

Review 1.  The piriform cortex and human focal epilepsy.

Authors:  David N Vaughan; Graeme D Jackson
Journal:  Front Neurol       Date:  2014-12-08       Impact factor: 4.003

2.  Effects of Low Frequency Stimulation on Spontaneous Inhibitory and Excitatory Post-Synaptic Currents in Hippocampal CA1 Pyramidal Cells of Kindled Rats.

Authors:  Samireh Ghafouri; Yaghoub Fathollahi; Saeed Semnanian; Amir Shojaei; Javad Mirnajafi-Zadeh
Journal:  Cell J       Date:  2016-09-26       Impact factor: 2.479

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.